Indicated for: peripheral vascular disease; circulatory disorders
Route of administration: injectable
Substance: xanthinol nicotinate (vasodilator)
ATC: C04AD02 (Cardiovascular system | Peripheral vasodilators | Purine derivatives)
Xantinol nicotinate is a medication used to improve blood circulation, particularly in conditions such as peripheral arterial disease, cerebrovascular insufficiency, and other vascular disorders. It is a derivative of nicotinic acid and xanthine, with vasodilatory properties and the ability to reduce blood viscosity. By dilating blood vessels, xantinol nicotinate enhances blood flow to tissues and organs.
The medication is administered orally or via injection, depending on the severity of the condition and the physician's recommendations. The dosage and duration of treatment are individually adjusted based on the patient's response.
Common side effects include skin flushing, a sensation of warmth, nausea, dizziness, and headaches. In rare cases, severe adverse reactions such as hypotension, allergic reactions, or gastrointestinal disturbances may occur.
Patients using xantinol nicotinate should be monitored for signs of adverse reactions, especially those with cardiovascular or hepatic conditions. The medication is an effective option for improving blood circulation, helping to alleviate symptoms associated with vascular disorders.